Insider Title Company Date Price Return Shares Value
Viking Global Investors Lp Non-Executive RayzeBio, Inc. (RYZB) 2023-09-19 $18.00 247.2% 1,388,889 $25,000,002
Viking Global Investors Lp Non-Executive RayzeBio, Inc. (RYZB) 2023-09-19 $18.00 247.2% 1,388,889 $25,000,002
Viking Global Investors Lp Non-Executive Inhibrx, Inc. (INBX) 2023-08-28 $19.35 -17.1% 511,627 $9,899,982
Viking Global Investors Lp Non-Executive 4D Molecular Therapeutics, Inc. (FDMT) 2023-05-09 $16.00 -3.1% 850,000 $13,600,000
Viking Global Investors Lp Non-Executive Inhibrx, Inc. (INBX) 2022-10-07 $30.00 -46.5% 1,333,333 $39,999,857
Viking Global Investors Lp Non-Executive Amylyx Pharmaceuticals, Inc. (AMLX) 2022-01-11 $19.00 -88.4% 2,300,000 $43,700,000
Viking Global Investors Lp Non-Executive PROCEPT BioRobotics Corp (PRCT) 2021-09-17 $35.00 118.1% 400,000 $14,000,000
Viking Global Investors Lp Non-Executive Rallybio Corp (RLYB) 2021-07-29 $13.00 -91.5% 806,000 $10,478,000
Viking Global Investors Lp Non-Executive 4D Molecular Therapeutics Inc. (FDMT) 2020-12-15 $23.00 -32.6% 1,100,000 $25,300,000
Viking Global Investors Lp Non-Executive Inhibrx, Inc. (INBX) 2020-08-26 $18.92 -15.2% 180,219 $3,409,866
Viking Global Investors Lp Non-Executive Inhibrx, Inc. (INBX) 2020-08-25 $19.39 -17.3% 131,465 $2,548,688
Viking Global Investors Lp Non-Executive Zentalis Pharmaceuticals, Inc. (ZNTL) 2020-04-07 $18.00 -82.0% 725,000 $13,050,000
Return Profit / (loss) Cost
Total 22.7% $51,277,687 $225,986,397